BioProcess Algae and KD-Pharma Sign Commercial Supply Agreement for EPA-Rich Omega-3 Oils
28 Juni 2012 - 7:10PM
BioProcess Algae LLC, a sustainable algal feedstocks company, and
KD-Pharma Bexbach GmbH, part of the Fat & Lipids Division of
Bioseutica BV, a leading producer of highly purified
pharmaceutical-grade Omega-3 fatty acids, announced today that they
have entered a commercial supply agreement for the production of
EPA-rich Omega-3 oils for use in concentrated EPA products for
nutritional and/or pharmaceutical applications. Under the
agreement, BioProcess Algae will supply microalgal oils which will
be refined by KD-Pharma's proprietary Supercritical Fluid
Technology (KD-pur®) to produce highly-concentrated vegetable
sourced EPA oils.
"We are very pleased to be able to work side-by-side with the
industry leader for high-quality, highly-purified Omega-3 oils,"
said Tim Burns, CEO of BioProcess Algae. "Our strategy is to
continue to expand our co-location operations by growing
high-quality feedstock at attractive prices. We intend to integrate
additional off-takes to increase our operational efficiency,
continue to gain economies of scale and to enhance profitability,
and this agreement will enable us to expand commercial development
toward this goal. We see many synergies with KD-Pharma and are
excited to be working together."
"Bioseutica is committed to identifying the highest quality and
most sustainable sources for our natural ingredients," said Peter
Lembke, Vice President & Business Development Manager,
Bioseutica. "From the beginning of our relationship, it was clear
that BioProcess Algae shared our commitment to the environment
without compromising product quality. Securing access to their
algae oil will enable us to offer a unique, sustainable
vegetable-based EPA-rich product that cannot be found in the
marketplace today."
Bioseutica is based in Lugano, Switzerland and offers
purification, manufacturing and formulation for a variety of
products including lysozyme and trypsin enzymes for nutritional and
pharmaceutical applications. Bioseutica's Fats & Lipids
Division (KD-Pharma) is based in Bexbach, Germany and is the
leading producer of highly-purified, pharmaceutical-grade Omega-3
fatty acids. Bioseutica is the only manufacturer with the ability
to fully custom tailor the Omega-3 fatty acids formulation to
unique specifications and manufactures the highest concentrated
Omega-3s in the industry, including ultra-pure A1 Quality Oils.
KD-Pharma has received numerous certifications and awards for its
commitment to the environment. Their patented supercritical
CO2-based KD-pur® technology produces no toxic impurities nor does
it use toxic solvents. All byproducts are recycled or transformed
into energy.
BioProcess Algae LLC is a Portsmouth, RI based leader in
converting carbon dioxide (CO2) into sustainable algae feedstocks
for human nutrition, animal feeds, green chemicals and biofuels.
The company is currently running a commercial-scale facility that
demonstrates the full co-location benefits of capturing carbon from
an adjacent ethanol plant and converting it into high-quality
feedstocks for downstream partners. The facility is integrated with
the Green Plains Renewable Energy, Inc. ethanol plant in
Shenandoah, Iowa as BioProcess Grower Harvester™ bioreactors have
been tied directly into the plant's CO2 exhaust gas since October
2009. BioProcess shareholders are CLARCOR Inc. (NYSE:CLC), a global
provider of filtration products; BioProcess Holdings, a wastewater
purification technology group; and Green Plains Renewable Energy,
Inc. (Nasdaq:GPRE), North America's fourth largest ethanol
producer.
CONTACT: Sasha Forsen, Media Relations
Phone: (402) 658-1263
Dr. Peter Lembke
KD-Pharma GmbH
Germany
Phone: +49 6826 3006
Clarcor (NYSE:CLC)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Clarcor (NYSE:CLC)
Historical Stock Chart
Von Jul 2023 bis Jul 2024